NCT01163916
Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care
Phase: N/A
Role: Collaborator
Start: Jan 31, 2008
Completion: Nov 30, 2011